Novartis new analysis shows high consistency in lowering LDL-C in individual response with investigational inclisiran

Corporate Breaking News

Home : Novartis new analysis shows high consistency in lowering LDL-C in individual response with investigational inclisiran

Aug 31 2020	Novartis new analysis shows high consistency in lowering LDL-C in individual response with investigational inclisiran
EAST HANOVER, N.J., Aug. 30, 2020 /PRNewswire/ -- Novartis today announced results from a post-hoc analysis of pooled data from the Phase III ORION-10 and -11 trials evaluating the individual responses of patients on low-density lipoprotein cholesterol (LDL-C) reduction with inclisiran, a...


Source:https://www.prnewswire.com:443/news-releases/novartis-new-analysis-shows-high-consistency-in-lowering-ldl-c-in-individual-response-with-investigational-inclisiran-301120583.html

Related News
» Avianca Holdings S.A. Issues Statement on Debtor-in-Possession Financing and Government of Colombia Financing Commitment » Police: Slain gunman's mother, adult sister shot to death